Better Therapeutics, Inc.
BTTXDelisted May 16, 2024- Industry
- Services-Health Services
- SEC CIK
- 0001832415
Better Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Feb 13, 2024; 22 institutions reported holding it in 13F filings for Q4 2023, worth $281.2K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Better Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −2 vs. Q4 2022
- Shares held
- 1.45M
- −112.8K (−7.2%) vs. Q4 2022
- Total value
- $1.04M
- −$704.1K (−40.3%) vs. Q4 2022
- New holders
- 0
- 5 more added
- Sold out
- 2
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $1 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $37 |
| Q1 2024 | 3 | $1.45K |
| Q4 2023 | 22 | $281.2K |
| Q3 2023 | 18 | $931.1K |
| Q2 2023 | 15 | $1.17M |
| Q1 2023 | 15 | $1.04M |
| Q4 2022 | 17 | $1.75M |
| Q3 2022 | 16 | $3.11M |
| Q2 2022 | 14 | $2.77M |
| Q1 2022 | 14 | $7.16M |
| Q4 2021 | 20 | $16.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Better Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 57 | $40 | 0.00% | 00.0% | Unchanged |
| PSI Advisors, LLC | 65 | $46 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 200 | $140 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,954 | $2.77K | 0.00% | +3,749+1,828.8% | Added |
| Tower Research Capital LLC (TRC) | 9,146 | $6.00K | 0.00% | +2,636+40.5% | Added |
| Ameriprise Financial Inc | 15,000 | $10.5K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 14,791 | $10.8K | 0.00% | −5,466−27.0% | Reduced |
| Northern Trust Corp | 16,703 | $11.7K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 26,556 | $19.0K | 0.00% | +14,932+128.5% | Added |
| State Street Corp | 45,200 | $32.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 47,516 | $34.6K | 0.00% | −6,473−12.0% | Reduced |
| Geode Capital Management, LLC | 57,109 | $41.6K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 81,167 | $56.8K | 0.00% | +798+1.0% | Added |
| Vanguard Group Inc | 438,479 | $306.9K | 0.00% | +3,700+0.9% | Added |
| Farallon Capital Management, L.L.C. | 699,042 | $508.9K | 0.00% | −114,514−14.1% | Reduced |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −12,192−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −18−100.0% | Sold out |